Skip to main content
Clinical Trials/NCT06637982
NCT06637982
Not yet recruiting
Not Applicable

Extended Platelet Rich Fibrin in Mandibular Alveolar Ridge Splitting With Simultaneous Implant Placement

Mansoura University1 site in 1 country32 target enrollmentOctober 10, 2024
ConditionsRidge Splitting

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ridge Splitting
Sponsor
Mansoura University
Enrollment
32
Locations
1
Primary Endpoint
implant stability
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

Thirty two healthy implants will be selected from the outpatient clinic of the oral and maxillofacial department of Mansoura university to be included in this study for replacement of lost posterior teeth with limited bone width.

Registry
clinicaltrials.gov
Start Date
October 10, 2024
End Date
October 10, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient age 18 years old and older.
  • Patient's cooperation, motivation and good oral hygiene.
  • Atrophic posterior mandible of horizontal alveolar dimension range between 3 - 6 mm at the crest, with minimum 10 mm vertical height from the alveolar crest to the superior border of the inferior alveolar canal.
  • Absence of undercuts in buccal aspect of the ridge.
  • Favorable occlusion and no parafunctional habits.
  • Patients able to comply with the required recall visits.
  • No gender preface in selection of the patients.
  • Acceptable inter-arch space for the future prosthesis.

Exclusion Criteria

  • Any pathological condition at the site of surgery.
  • Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
  • Patient taking drugs that could affect bone healing process as immunosuppressive drugs and bisphosphonates.
  • Heavy smoking and alcoholism.
  • Parafunctional habits such as bruxism and clenching.
  • Signs of acute infection or pus discharge.
  • Untreated periodontal disease or bad oral hygiene.

Outcomes

Primary Outcomes

implant stability

Time Frame: 9 months

the stability of the implants will be evaluated by RFA with the Osstell Mentor device

alveolar ridge width

Time Frame: 9 months

alveolar ridge width will be measured preoperative, immediate postoperative and after 9 months

Study Sites (1)

Loading locations...

Similar Trials